FDA reviewers have little doubt that Rockwell Medical’s iron-replacement treatment for dialysis patients met its goals in late-stage trials, but the company, seeking agency approval, may have trouble convincing regulators that its Phase III results can translate into real-world benefits.

…read more

Source: Can Rockwell Medical win FDA approval for its dialysis drug?


0 No comments